# Phase-III Clinical Studies on Poly Herbal Anti-Diabetic Formulation

> **NCT07279909** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Hamdard University** · enrollment: 500 (actual)

## Conditions studied

- Diabetes Type 2
- Diabetes Mellitus, Experimental
- HbA1c
- Urinary Glucose
- Ability of Experimental Drug to Lower HbA1c Compare to Metformin

## Interventions

- **DRUG:** DIAB-PHC1
- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT07279909
- **Lead sponsor:** Hamdard University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-03-09
- **Primary completion:** 2025-08-01
- **Final completion:** 2026-05-20
- **Target enrollment:** 500 (ACTUAL)
- **Last updated:** 2025-12-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07279909

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07279909, "Phase-III Clinical Studies on Poly Herbal Anti-Diabetic Formulation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07279909. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*